CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Key Regulation Analysis
3.7. Market Share Analysis
3.8. Patent Landscape
3.9. Regulatory Guidelines
3.10. Value Chain Analysis
CHAPTER 4: GENE SYNTHESIS MARKET, BY METHOD
4.1. Overview
4.1.1. Market size and forecast
4.2. Solid Phase Synthesis
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. PCR Based Enzyme Synthesis
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. CHIP Based DNA Synthesis
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: GENE SYNTHESIS MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Academic and Research Institutes,
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Biotech and Pharmaceutical Companies,
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Diagnostic Laboratories
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Other
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: GENE SYNTHESIS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Method
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Method
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Method
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Method
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Method
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. UK
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Method
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. Germany
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Method
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. France
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Method
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Spain
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Method
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Italy
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Method
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Method
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Method
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Method
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. India
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Method
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. Japan
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Method
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. South Korea
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Method
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. Australia
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Method
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Method
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Method
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Method
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Method
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. UAE
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Method
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. South Africa
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Method
6.5.4.4.3. Market size and forecast, by End User
6.5.4.5. Rest of LAMEA
6.5.4.5.1. Key market trends, growth factors and opportunities
6.5.4.5.2. Market size and forecast, by Method
6.5.4.5.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Genscript Technology
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.2. Brooks Automation, Inc.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.3. Boster Biological Technology
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.4. Twist Bioscience
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.5. Codex DNA
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.6. Biomatik
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.7. promab biotechnologies, inc.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.8. Thermo Fisher Scientific, Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.9. Integrated DNA Technologies, Inc.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.10. OriGene Technologies, Inc.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
TABLE 01. GLOBAL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 02. GENE SYNTHESIS MARKET FOR SOLID PHASE SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 03. GENE SYNTHESIS MARKET FOR PCR BASED ENZYME SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 04. GENE SYNTHESIS MARKET FOR CHIP BASED DNA SYNTHESIS, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 05. GLOBAL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 06. GENE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 07. GENE SYNTHESIS MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES,, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 08. GENE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 09. GENE SYNTHESIS MARKET FOR OTHER, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 10. GENE SYNTHESIS MARKET, BY REGION, 2021-2031 (REVENUE, $THOUSAND)
TABLE 11. NORTH AMERICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 12. NORTH AMERICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 13. NORTH AMERICA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 14. U.S. GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 15. U.S. GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 16. CANADA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 17. CANADA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 18. MEXICO GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 19. MEXICO GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 20. EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 21. EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 22. EUROPE GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 23. UK GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 24. UK GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 25. GERMANY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 26. GERMANY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 27. FRANCE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 28. FRANCE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 29. SPAIN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 30. SPAIN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 31. ITALY GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 32. ITALY GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 33. REST OF EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 34. REST OF EUROPE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 35. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 36. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 37. ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 38. CHINA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 39. CHINA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 40. INDIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 41. INDIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 42. JAPAN GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 43. JAPAN GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 44. SOUTH KOREA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 45. SOUTH KOREA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 46. AUSTRALIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 47. AUSTRALIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 48. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 49. REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 50. LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 51. LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 52. LAMEA GENE SYNTHESIS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $THOUSAND)
TABLE 53. BRAZIL GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 54. BRAZIL GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 55. SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 56. SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 57. UAE GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 58. UAE GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 59. SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 60. SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 61. REST OF LAMEA GENE SYNTHESIS MARKET, BY METHOD, 2021-2031 (REVENUE, $THOUSAND)
TABLE 62. REST OF LAMEA GENE SYNTHESIS MARKET, BY END USER, 2021-2031 (REVENUE, $THOUSAND)
TABLE 63. GENSCRIPT TECHNOLOGY: KEY EXECUTIVES
TABLE 64. GENSCRIPT TECHNOLOGY: COMPANY SNAPSHOT
TABLE 65. BROOKS AUTOMATION, INC.: KEY EXECUTIVES
TABLE 66. BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT
TABLE 67. BOSTER BIOLOGICAL TECHNOLOGY: KEY EXECUTIVES
TABLE 68. BOSTER BIOLOGICAL TECHNOLOGY: COMPANY SNAPSHOT
TABLE 69. TWIST BIOSCIENCE: KEY EXECUTIVES
TABLE 70. TWIST BIOSCIENCE: COMPANY SNAPSHOT
TABLE 71. CODEX DNA: KEY EXECUTIVES
TABLE 72. CODEX DNA: COMPANY SNAPSHOT
TABLE 73. BIOMATIK: KEY EXECUTIVES
TABLE 74. BIOMATIK: COMPANY SNAPSHOT
TABLE 75. PROMAB BIOTECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 76. PROMAB BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 77. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 78. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 79. INTEGRATED DNA TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 80. INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 81. ORIGENE TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 82. ORIGENE TECHNOLOGIES, INC.: COMPANY SNAPSHOT
